Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Modern NNRTI regimens can be effective with 85% adherence

Some modern HIV treatment regimens can achieve viral suppression with adherence rates as low as 85%, investigators from the US Veteran Aging Cohort Study report in the

Published
12 May 2015
By
Michael Carter
Five antiretroviral combinations associated with increased risk of a cardiovascular event

Treatment with four individual and five combinations of anti-HIV drugs is associated with an increased risk of a cardiovascular event, investigators from the United States report in the

Published
08 May 2015
By
Michael Carter
US guidelines shift to integrase-based combinations for first-line treatment: Atripla relegated due to side effects

The rationale for dropping Atripla is due to concerns about the tolerability of efavirenz, especially the high rate of central nervous system related toxicities. Although this has been a long-standing community concern, DHHS guidelines have consistently recommended efavirenz in previous editions. This tolerability statement is made in the year that efavirenz comes off patent.

Published
06 May 2015
From
i-Base
HIV infection and low CD4 count associated with hardening of arteries

HIV infection is associated with an increased risk of hardening of the arteries, investigators report in the online edition of Clinical Infectious Diseases. The US study compared changes

Published
06 May 2015
By
Michael Carter
Researchers “un-can” the HIV virus

If the human immunodeficiency virus (HIV) is a bit like a hermetically sealed tin can no one has yet been able to break open, the good news is that researchers at the CHUM Research Centre, affiliated with the University of Montreal, have identified a way to use a “can opener” to force the virus to open up and to expose its vulnerable parts, allowing the immune system cells to then kill the infected cells.

Published
05 May 2015
From
Univesity of Montreal
People who don’t tell anyone else their HIV status have as good health outcomes as other people living with HIV

A large survey of people attending HIV clinics in the UK has found that those individuals who chose not to disclose their HIV status to other people

Published
01 May 2015
By
Roger Pebody
New subdermal implant delivers potent antiretroviral drugs

A novel, subdermal implant delivering potent antiretroviral drugs shows extreme promise in stopping the spread of HIV, researchers report. Scientists say that they have developed a matchstick size implant, similar to a contraceptive implant, that successfully delivers a controlled, sustained release of tenofovir alafenamide up to 40 days in dogs with no adverse side effects.

Published
29 April 2015
From
Science Daily
HIV prevention and risk behaviors follow weekly patterns

The peak time for seeking information on topics related to HIV, such as prevention and testing, is at the beginning of the week, while risky sexual behaviors tend to increase on the weekends and adherence to antiretroviral therapy (ART) is slightly lower on weekends, according to a new analysis.

Published
27 April 2015
From
Eurekalert Medicine & Health
Many people living with HIV willing to take part in cure research, despite its risks

There is a strong interest among people living with HIV in studies towards an HIV cure, with many potential participants willing to consider antiretroviral treatment interruption. Respondents

Published
24 April 2015
By
Roger Pebody
Treatment outcomes no better with single tablet regimens than individual tablets

One pill a day HIV treatments such as Atripla, Stribild and Eviplera have the same rates of virological failure, drug resistance and side-effects as multiple tablet regimens,

Published
23 April 2015
By
Roger Pebody

Filter by country